Cited by 128Multiple Sclerosis Research StudiesCancer survivorship and carePsychological Well-being and Life Satisfaction

Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients

Hart, Stacey, Fonareva, Irina, Merluzzi, Natalia, Mohr, David C.·2005·Quality of Life Research

Abstract

Depression, a common problem in multiple sclerosis (MS), is generally associated with poorer quality of life (QOL). However, it is unclear whether treating depression also extends to better perceived QOL. Understanding QOL in MS has been limited by narrow definitions and exclusive focus on symptomology, with little emphasis on positive aspects of QOL. This study examined the impact of treating depression on QOL in 60 patients with a relapsing form of MS and moderate to severe depression, who were randomly assigned to one of three validated 16-week treatments for depression: individual cognitive-behavioral therapy, group psychotherapy, or sertraline. QOL was measured by the MSQOL-54, a version of the SF-36 adapted for MS, and Ryff's scales of psychological well-being, which measure positive attitudes and functioning. Depression and QOL were measured at baseline and immediately following treatment completion. Controlling for baseline neurological impairment and baseline QOL scores, regression analyses showed treating depression was significantly associated with improvements in the MSQOL-54 scales (R2s = 0.19-0.55, p < 0.001) and in four of the six scales of psychological well-being: environmental mastery (R2 = 0.13, p < 0.001), positive relations (R2 = 0.08, p < 0.001), purpose in life (R2 = 0.16, p < 0.001), and self-acceptance (R2 = 0.26, p < 0.001). Findings suggest treating depression influences both the negative and positive aspects of QOL and underscore the importance of…

Integrity signals

Registry

Crossref · 10.1007/s11136-004-1364-z

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These and other studies have often used individual therapy, and findings have mainly focused upon single dimensions of well-being, e.g., depression or fatigue.

    “However, these and other studies have often used individual therapy, and findings have mainly focused upon single dimensions of well-being, e.g., depression or fatigue.”
  • Several previous controlled trials of cognitive-behavioral interventions have shown benefits upon depression, fatigue, or anxiety in patients with MS.

    “Several previous controlled trials of cognitive-behavioral interventions have shown benefits upon depression, fatigue, or anxiety in patients with MS.19,38,39”
  • Improvements in well-being or HRQOL as primary aims among more broadly representative samples of patients with multiple sclerosis have been neglected.

    “Improvements in well-being or HRQOL19 as primary aims among more broadly representative samples of patients with MS have been neglected”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C.
Affiliations
San Francisco VA Medical Center (US)
Corresponding author
Hart, Stacey
Venue
Quality of Life Research
Published
2005-04
Volume
14
Issue
3
Pages
695-703
ISSN
  • 0962-9343 (ISSN-L)
  • 1573-2649
OpenAlex
W2053627258
Cited by
128
References
9
Citations by year
2026: 1 · 2025: 6 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 8 · 2014: 7 · 2013: 9 · 2012: 9
FWCI
6.21
Type
journal article
Language
en
Open access
closed
Locations
  • Quality of Life Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Multiple Sclerosis Society
  • National Institute of Mental Health (R01-MH59708, R01MH059708)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Social Psychology › Psychological Well-being and Life Satisfaction
Keywords
depression, multiple sclerosis, quality of life, psychological well-being, cognitive behavioral therapy, group therapy, sertraline, relapsing multiple sclerosis, MSQOL-54, Ryff scale, environmental mastery, positive relationships, meaning of life, self-acceptance
MeSH terms
Adult, Antidepressive Agents, Behavior Therapy, Depressive Disorder, Female, Humans, Male, Multiple Sclerosis, Psychotherapy, Group, Quality of Life, Regression Analysis, Severity of Illness Index, Sickness Impact Profile, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review